Omeros Corporation (OMER)
Healthcare
Biotechnology
12.60 $
+6.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 | -33 | -35 | -42 | -46 | -32 | -29 | -36 | -22 | -18 | -40 | -15 | -95 | |
| 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | -2.0 | 0.2 | -1.3 | |
| 2.8 | 3.2 | 2.7 | 2.7 | 2.8 | 2.6 | 2.4 | 2.4 | 2.1 | 1.9 | 1.7 | 1.9 | 7.6 | |
| 2.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 9.1 | 17 | 6.6 | -0.3 | 16 | 5.2 | 8.0 | 1.9 | 18 | 14 | -0.6 | 5.2 | 37 | |
| 0.3 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 35 | 57 | – | -62 | 73 | 36 | – | 39 | 21 | -6.9 | 112 | 29 | 155 | |
| 0.1 | 0.0 | – | -12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.2 | -4.2 | |
| 0.5 | – | – | – | – | 11 | -20 | -1.9 | -5.2 | 6.5 | -89 | -22 | -109 | |
| -0.3 | -0.5 | -105 | 98 | -27 | -4.6 | -4.1 | -1.8 | -1.7 | 26 | -64 | -22 | -62 | |
| 2.8 | 24 | -24 | -5.3 | 0.3 | -0.6 | 1.9 | 0.9 | -2.4 | 0.5 | 7.3 | -7.8 | -2.4 | |
| -33 | -33 | -35 | -42 | -46 | -32 | -29 | -36 | -22 | -18 | -40 | -15 | -95 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.